Vascarta Receives FDA Orphan Drug Designation for Vasceptor® in the Treatment of Sickle Cell Disease ...Middle East

SUMMIT, N.J., June 12, 2025 /PRNewswire/ -- Vascarta Inc., a biopharmaceutical company committed to advancing innovative therapies for underserved patient populations, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead drug...

Read More Details
Finally We wish PressBee provided you with enough information of ( Vascarta Receives FDA Orphan Drug Designation for Vasceptor® in the Treatment of Sickle Cell Disease )

Also on site :

• Business news live: Oil prices surge after Israel attacks Iran, FTSE 100 falls after all time high
• Iran launches 100 drones at Israel in response to missile attack as markets reel
• Los Premios MWCapital reconocen los proyectos tecnológicos internacionales con mayor impacto en la sostenibilidad